Market cap
$64 Mln
Revenue (TTM)
$80 Mln
P/E Ratio
--
P/B Ratio
6.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-3.5 %
-
ROCE
-- %
-
Industry P/E
50.52
-
EV/EBITDA
-6.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1
-
Face value
--
-
Shares outstanding
49,954,200
5 Years Aggregate
CFO
$-161.08 Mln
EBITDA
$-157.84 Mln
Net Profit
$-208.36 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Akoya BioSciences (AKYA)
| -43.7 | 4.9 | 8.4 | -44.6 | -54.1 | -- | -- |
|
BSE Sensex*
| -11.8 | -2.9 | -8.2 | -8.4 | 6.1 | 7.5 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Akoya BioSciences (AKYA)
| -52.8 | -49.0 | -37.5 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Akoya BioSciences (AKYA)
|
1.3 | 64.4 | 80.0 | -47.5 | -37.3 | -- | -- | 6.5 |
| 3.9 | 106.3 | 19.5 | -5.2 | -27.7 | -17.4 | -- | 3.5 |
Shareholding Pattern
View DetailsAbout Akoya BioSciences (AKYA)
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers... PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Read more
-
President, CEO & Director
Mr. Brian McKelligon
-
President, CEO & Director
Mr. Brian McKelligon
-
Headquarters
Marlborough, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Akoya BioSciences (AKYA)
What is the current share price of Akoya BioSciences Inc (AKYA) Today?
The share price of Akoya BioSciences Inc (AKYA) is $1.29 (NASDAQ) as of 16-Jul-2025 09:30 EDT. Akoya BioSciences Inc (AKYA) has given a return of -54.11% in the last 3 years.
What is the current PB & PE ratio of Akoya BioSciences Inc (AKYA)?
Since, TTM earnings of Akoya BioSciences Inc (AKYA) is negative, P/E ratio is not available.
The P/B ratio of Akoya BioSciences Inc (AKYA) is 6.45 times as on 16-Jul-2025, a 113 premium to its peers’ median range of 3.03 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-2.05
|
14.94
|
|
2023
|
-3.78
|
4.46
|
|
2022
|
-5.15
|
6.21
|
|
2021
|
-13.28
|
4.70
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Akoya BioSciences Inc (AKYA)?
The 52-week high and low of Akoya BioSciences Inc (AKYA) are Rs 3.42 and Rs 0.93 as of 02-Jun-2026.
What is the market cap of Akoya BioSciences Inc (AKYA)?
Akoya BioSciences Inc (AKYA) has a market capitalisation of $ 64 Mln as on 16-Jul-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Akoya BioSciences Inc (AKYA)?
Before investing in Akoya BioSciences Inc (AKYA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.